1.
Emerg Infect Dis
; 27(2): 636-638, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-993266
ABSTRACT
We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%-28.5%).